Tingting Cai1, Qingmei Huang1, Fulei Wu1, Changrong Yuan2. 1. School of Nursing, Fudan University, 305 Fenglin Road, Shanghai, 200032, China. 2. School of Nursing, Fudan University, 305 Fenglin Road, Shanghai, 200032, China. yuancr@fudan.edu.cn.
Abstract
BACKGROUND: The diagnosis of breast cancer and the subsequent treatment undermine patients' participation in social activities. This study aimed to carry out a cross-cultural adaption and analysis of the construct validity and reliability of the Chinese version of the PROMIS social function short forms in patients with breast cancer. METHODS: This study utilized a cross-sectional research design, and was registered in the Chinese Clinical Trial Registry (ChiCTR2000035439). After a standardized cross-cultural adaption process, a psychometric evaluation was performed of the Chinese version of the PROMIS social function short forms. Using convenience sampling, eligible patients with breast cancer from tertiary hospitals in China were enrolled from January 2019 to July 2020. Participants completed the sociodemographic information questionnaire, the PROMIS social function short forms, the Functional Assessment of Cancer Therapy-Breast, the PROMIS emotional support short form and the PROMIS anxiety short form. RESULTS: Data were collected from a sample of 633 patients whose mean age was 48.1 years. The measures showed an absence of floor and ceiling effects. Regarding construct validity, the results of confirmatory factor analysis supported the original two-factor structure of the PROMIS social function short forms. In addition, the measures were found to have acceptable known-group validity, measurement invariance, and convergent and discriminate validity. Regarding reliability, the Cronbach's α was high for all items (> 0.70). CONCLUSION: The Chinese version of the PROMIS social function short forms was demonstrated to be a valid and reliable measure for the assessment of social function in Chinese patients with breast cancer. Additional psychometric evaluation is needed to draw firm conclusions.
BACKGROUND: The diagnosis of breast cancer and the subsequent treatment undermine patients' participation in social activities. This study aimed to carry out a cross-cultural adaption and analysis of the construct validity and reliability of the Chinese version of the PROMIS social function short forms in patients with breast cancer. METHODS: This study utilized a cross-sectional research design, and was registered in the Chinese Clinical Trial Registry (ChiCTR2000035439). After a standardized cross-cultural adaption process, a psychometric evaluation was performed of the Chinese version of the PROMIS social function short forms. Using convenience sampling, eligible patients with breast cancer from tertiary hospitals in China were enrolled from January 2019 to July 2020. Participants completed the sociodemographic information questionnaire, the PROMIS social function short forms, the Functional Assessment of Cancer Therapy-Breast, the PROMIS emotional support short form and the PROMIS anxiety short form. RESULTS: Data were collected from a sample of 633 patients whose mean age was 48.1 years. The measures showed an absence of floor and ceiling effects. Regarding construct validity, the results of confirmatory factor analysis supported the original two-factor structure of the PROMIS social function short forms. In addition, the measures were found to have acceptable known-group validity, measurement invariance, and convergent and discriminate validity. Regarding reliability, the Cronbach's α was high for all items (> 0.70). CONCLUSION: The Chinese version of the PROMIS social function short forms was demonstrated to be a valid and reliable measure for the assessment of social function in Chinese patients with breast cancer. Additional psychometric evaluation is needed to draw firm conclusions.
Entities:
Keywords:
Breast cancer; PROMIS; Psychometric analysis; Social function
Authors: David Cella; Seung W Choi; David M Condon; Ben Schalet; Ron D Hays; Nan E Rothrock; Susan Yount; Karon F Cook; Richard C Gershon; Dagmar Amtmann; Darren A DeWalt; Paul A Pilkonis; Arthur A Stone; Kevin Weinfurt; Bryce B Reeve Journal: Value Health Date: 2019-05 Impact factor: 5.725
Authors: David Cella; William Riley; Arthur Stone; Nan Rothrock; Bryce Reeve; Susan Yount; Dagmar Amtmann; Rita Bode; Daniel Buysse; Seung Choi; Karon Cook; Robert Devellis; Darren DeWalt; James F Fries; Richard Gershon; Elizabeth A Hahn; Jin-Shei Lai; Paul Pilkonis; Dennis Revicki; Matthias Rose; Kevin Weinfurt; Ron Hays Journal: J Clin Epidemiol Date: 2010-08-04 Impact factor: 6.437
Authors: Maria Cristina Lima E Silva; Tânia Maria da Silva Mendonça; Carlos Henrique Martins da Silva; Rogério de Melo Costa Pinto Journal: Trends Psychiatry Psychother Date: 2015 Apr-Jun
Authors: Sara Ahmed; Richard A Berzon; Dennis A Revicki; William R Lenderking; Carol M Moinpour; Ethan Basch; Bryce B Reeve; Albert W Wu Journal: Med Care Date: 2012-12 Impact factor: 2.983
Authors: Elizabeth A Hahn; Jennifer L Beaumont; Paul A Pilkonis; Sofia F Garcia; Susan Magasi; Darren A DeWalt; David Cella Journal: J Clin Epidemiol Date: 2016-02-27 Impact factor: 6.437